Citicoline sodium

CAS No. 33818-15-4

Citicoline sodium( Cytidine 5'-diphosphocholine | Flussorex | Gerolin | Logan | Neurotron | Sinkron )

Catalog No. M14145 CAS No. 33818-15-4

Donor of choline in biosynthesis of choline-containing phosphoglycerides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 28 In Stock
100MG 39 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Citicoline sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Donor of choline in biosynthesis of choline-containing phosphoglycerides.
  • Description
    Donor of choline in biosynthesis of choline-containing phosphoglycerides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cytidine 5'-diphosphocholine | Flussorex | Gerolin | Logan | Neurotron | Sinkron
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    phosphatidylcholine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    33818-15-4
  • Formula Weight
    510.31
  • Molecular Formula
    C14H25N4NaO11P2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=P(OP([O-])(OC[C@@H]1O[C@H](N2C=CC(N)=NC2=O)[C@@H](O)[C@H]1O)=O)([O-])OCC[N+](C)(C)C.[Na+]
  • Chemical Name
    Sodium [[(2S,3R,4S,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Conant R, Schauss AG. Altern Med Rev. 2004 Mar;9(1):17-3
molnova catalog
related products
  • KT-474

    KT-474 (KYM-001) is a PROTAC degrader targeting interleukin-1 receptor-associated kinase 4 (IRAK4) with antitumor activity for the study of autoimmune, inflammatory, and cardiovascular disease disorders.

  • SBE 13 hydrochloride

    SBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no inhibition om Aurora A kinase, Plk2/3.

  • GW6340

    GW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.